The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR1

5 Oct 2020 07:00

RNS Number : 0214B
Dev Clever Holdings PLC
05 October 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Dev Clever Holdings plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Chris Akers

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

02/10/2020

6. Date on which issuer notified (DD/MM/YYYY):

02/10/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.02%

9.02%

471,219,794

Position of previous notification (if

applicable)

8.25%

8.25%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

42,500,000

9.02%

SUBTOTAL 8. A

42,500,000

9.02%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Chris Akers

9.02%

9.02%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

These shares are held in Chris Akers SIPP

 

Place of completion

London, UK

Date of completion

02/10/2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLKKNBPNBDDBKK
Date   Source Headline
21st Dec 20207:00 amRNSAgreement
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:36 pmRNSPrice Monitoring Extension
7th Dec 202011:00 amRNSPrice Monitoring Extension
1st Dec 20207:00 amRNSUpdate on Subscription Agreement
13th Nov 20202:30 pmRNSHolding(s) in Company
6th Nov 20207:00 amRNSHeads of Terms
2nd Nov 20207:00 amRNSUpdate To Subscription Agreement
27th Oct 20202:15 pmRNSHolding(s) in Company
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSTR1
5th Oct 20207:00 amRNSTotal Voting Rights
23rd Sep 20207:00 amRNSNew Appointment
17th Sep 20207:00 amRNSPartnership announcement
16th Sep 202010:10 amRNSHolding(s) in Company
15th Sep 20202:15 pmRNSHolding in Company
14th Sep 20207:00 amRNSExercise of warrants
11th Sep 202010:00 amRNSHolding(s) in Company
10th Sep 20207:00 amRNSTrading update and new contract
8th Sep 20204:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSIssue of Equity
3rd Sep 20207:00 amRNSIssue of Equity
1st Sep 20207:00 amRNSUpdate to Right to Subscribe
18th Aug 20203:45 pmRNSHolding(s) in Company
3rd Aug 20207:01 amRNSDirector/PDMR Shareholding
3rd Aug 20207:00 amRNSIssue of Equity
29th Jul 20207:00 amRNSIssue of equity and conversion of debt
27th Jul 20207:05 amRNSHalf-year Report
27th Jul 20207:00 amRNSUpdate to Right to Subscribe
17th Jul 202010:00 amRNSHolding(s) in Company
16th Jul 20209:31 amRNSHolding(s) in Company
15th Jul 20207:00 amRNSHolding(s) in Company
10th Jul 20203:00 pmRNSHolding(s) in Company
9th Jul 20207:00 amRNSProduct Launch
6th Jul 20207:00 amRNSCommercial agreement
8th Jun 20202:05 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSVirtual Open Week
26th May 20207:00 amRNSDirectorate Change
22nd May 20207:00 amRNSExercise of employee share options
21st May 202010:30 amRNSDirector/PDMR Shareholding
14th May 20203:50 pmRNSDirector/PDMR Shareholding
13th May 202010:30 amRNSRight to Subscribe
13th May 202010:30 amRNSDirector/PDMR Shareholding
6th May 20207:00 amRNSProduct Launch
4th May 20209:00 amRNSPrice Monitoring Extension
30th Apr 20201:30 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSContract
20th Apr 20204:41 pmRNSSecond Price Monitoring Extn
20th Apr 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.